Aardvark Therapeutics, Inc. Common Stock
Price Action
Technical Summary
WEAKENINGAardvark Therapeutics, Inc. Common Stock is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 13), showing significant lag compared to the market leaders. Earnings contraction of 130% provides fundamental context to the price action. Investors should exercise caution due to high volatility (109% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.51 | +20.61% | ABOVE |
| 50 SMA | $4.76 | +14.21% | ABOVE |
| 100 SMA | $5.67 | -4.10% | BELOW |
| 150 SMA | $8.32 | -34.64% | BELOW |
| 200 SMA | $9.27 | -41.29% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is AARD in an uptrend right now?
AARD has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is AARD overbought or oversold?
AARD's RSI (14) is 70. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is AARD outperforming the market?
AARD has a Relative Strength (RS) Rating of 13 out of 99. AARD is currently lagging the broader market.
Where is AARD in its 52-week range?
AARD is trading at $5.44, which is 30% of its 52-week high ($17.94) and 14% above its 52-week low ($3.35).
How volatile is AARD?
AARD has a Beta of 2.49 and 52-week volatility of 109%. It's more volatile than the S&P 500 - expect bigger swings.